Clorox Co. (CLX) Stake Decreased by CIBC World Markets Inc.
CIBC World Markets Inc. reduced its stake in Clorox Co. (NYSE:CLX) by 70.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,846 shares of the company’s stock after selling 40,780 shares during the period. CIBC World Markets Inc.’s holdings in Clorox were worth $2,109,000 as of its most recent filing with the SEC.
Other institutional investors also recently bought and sold shares of the company. Fisher Asset Management LLC raised its position in Clorox by 6.9% in the second quarter. Fisher Asset Management LLC now owns 2,982 shares of the company’s stock valued at $411,000 after buying an additional 192 shares in the last quarter. Keel Point LLC raised its position in shares of Clorox by 0.5% in the second quarter. Keel Point LLC now owns 7,512 shares of the company’s stock worth $1,040,000 after buying an additional 37 shares during the period. Creative Planning raised its position in shares of Clorox by 8.6% in the second quarter. Creative Planning now owns 13,252 shares of the company’s stock worth $1,834,000 after buying an additional 1,046 shares during the period. DAVENPORT & Co LLC raised its position in shares of Clorox by 3.4% in the second quarter. DAVENPORT & Co LLC now owns 3,039 shares of the company’s stock worth $421,000 after buying an additional 99 shares during the period. Finally, Gateway Investment Advisers LLC raised its position in shares of Clorox by 1.2% in the second quarter. Gateway Investment Advisers LLC now owns 11,646 shares of the company’s stock worth $1,612,000 after buying an additional 137 shares during the period. 69.32% of the stock is owned by hedge funds and other institutional investors.
Shares of Clorox Co. (NYSE:CLX) traded down 1.81% on Wednesday, hitting $115.56. The company had a trading volume of 1,833,760 shares. The stock’s 50-day moving average is $117.36 and its 200 day moving average is $127.31. The company has a market capitalization of $14.88 billion, a price-to-earnings ratio of 23.26 and a beta of 0.36. Clorox Co. has a 52 week low of $111.24 and a 52 week high of $140.47.
Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, November 2nd. The company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.42 by $0.06. Clorox had a net margin of 11.27% and a return on equity of 250.82%. The company had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.24 billion. During the same period in the previous year, the business earned $1.32 EPS. Clorox’s revenue for the quarter was up 3.8% compared to the same quarter last year. Equities analysts expect that Clorox Co. will post $5.32 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 10th. Shareholders of record on Wednesday, January 25th will be paid a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a yield of 2.77%. The ex-dividend date is Monday, January 23rd. Clorox’s dividend payout ratio (DPR) is presently 64.26%.
A number of brokerages have weighed in on CLX. B. Riley reissued a “neutral” rating and issued a $109.00 target price on shares of Clorox in a research report on Thursday, August 4th. Goldman Sachs Group Inc. reissued a “neutral” rating and issued a $130.00 target price on shares of Clorox in a research report on Thursday, August 4th. Citigroup Inc. boosted their target price on Clorox from $134.00 to $144.00 and gave the stock a “neutral” rating in a research report on Monday, August 8th. Jefferies Group reissued a “hold” rating on shares of Clorox in a research report on Wednesday, August 3rd. Finally, Royal Bank Of Canada decreased their target price on Clorox from $121.00 to $115.00 and set a “sector perform” rating for the company in a research report on Thursday, November 3rd. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $128.50.
In other Clorox news, EVP Laura Stein sold 38,882 shares of the stock in a transaction dated Friday, September 2nd. The stock was sold at an average price of $131.69, for a total value of $5,120,370.58. Following the completion of the sale, the executive vice president now directly owns 48,501 shares in the company, valued at $6,387,096.69. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.74% of the stock is owned by company insiders.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.